Applies to Employer and ACA Marketplace plans.
Covered with requirementsQualification pathways
You can qualify through any one of these.
Type 2 Diabetes Mellitus – age-based approval
All of:
- Diagnosis of type 2 diabetes mellitus
- Patient is ≥ 10 years of age
Documentation to bring
- Documentation of type 2 diabetes mellitus diagnosis
- Patient age ≥ 10 years
Approval and renewal
- Initial approval: 12 months
Not covered when
- Weight loss without type 2 diabetes diagnosis
- Prediabetes/diabetes prevention
- Metabolic syndrome without type 2 diabetes
- Concomitant use with other GLP-1 agonists or GLP-1/GIP agonists
- Type 1 diabetes
Policy note: Automation exists: a Mounjaro claim will auto-adjudicate if the patient meets the lookback for one oral medication for diabetes (not including Rybelsus or single-entity metformin) and patient is ≥ 10 years of age (updated from ≥ 18 years of age effective 01/07/2026). If either condition is not met, full PA criteria apply. Zepbound (tirzepatide) is not included in this policy as it is not indicated for diabetes.
Policy effective May 6, 2026 · verified June 2, 2026 · source: Cigna — GLP-1 coverage criteria (Policy 360) · View policy document (PDF)